A Study to Evaluate the Efficacy and Safety of AD-218
ConditionMixed Dyslipidemia
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age19+
SponsorAddpharma Inc.
About this trial
The purpose of this study is to evaluate the efficacy and safety of AD-218
Eligibility criteria
Qualifiers
A man or woman over 19 years old.
Sign on ICF prior to study participation
Disqualifiers
History of Fibromyalgia, Myopathy etc (CK ≥ 2 X ULN)
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-218
- AD-218A
Treatment groups
520 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov